JP2022548247A5 - - Google Patents

Info

Publication number
JP2022548247A5
JP2022548247A5 JP2022516117A JP2022516117A JP2022548247A5 JP 2022548247 A5 JP2022548247 A5 JP 2022548247A5 JP 2022516117 A JP2022516117 A JP 2022516117A JP 2022516117 A JP2022516117 A JP 2022516117A JP 2022548247 A5 JP2022548247 A5 JP 2022548247A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
formula
alkyl group
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022516117A
Other languages
English (en)
Japanese (ja)
Other versions
JP7680433B2 (ja
JP2022548247A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/075458 external-priority patent/WO2021048342A1/en
Publication of JP2022548247A publication Critical patent/JP2022548247A/ja
Publication of JP2022548247A5 publication Critical patent/JP2022548247A5/ja
Application granted granted Critical
Publication of JP7680433B2 publication Critical patent/JP7680433B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022516117A 2019-09-13 2020-09-11 抗菌化合物 Active JP7680433B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19197183.7 2019-09-13
EP19197183 2019-09-13
PCT/EP2020/075458 WO2021048342A1 (en) 2019-09-13 2020-09-11 Antibacterial compounds

Publications (3)

Publication Number Publication Date
JP2022548247A JP2022548247A (ja) 2022-11-17
JP2022548247A5 true JP2022548247A5 (https=) 2023-09-19
JP7680433B2 JP7680433B2 (ja) 2025-05-20

Family

ID=67956507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022516117A Active JP7680433B2 (ja) 2019-09-13 2020-09-11 抗菌化合物

Country Status (10)

Country Link
US (1) US20220340564A1 (https=)
EP (1) EP4028399B1 (https=)
JP (1) JP7680433B2 (https=)
CN (1) CN114423758B (https=)
AU (1) AU2020346370B2 (https=)
BR (1) BR112022003799A2 (https=)
CA (1) CA3149868A1 (https=)
ES (1) ES2978573T3 (https=)
MX (1) MX2022003037A (https=)
WO (1) WO2021048342A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348510B (zh) 2015-09-17 2022-01-04 圣母大学 针对分枝杆菌感染有用的含有苄胺的杂环化合物以及组合物
EP4308239A1 (en) * 2021-03-16 2024-01-24 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
IL312366A (en) 2021-10-28 2024-06-01 Janssen Sciences Ireland Unlimited Co Imidazopyridine amides and related compounds for use in the treatment of bacterial infections
EP4296674A1 (en) 2022-06-20 2023-12-27 Université Toulouse III - Paul Sabatier Innovative molecules decreasing virulence of mycobacterium for the treatment of tuberculosis
WO2024089170A1 (en) 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2024223859A1 (en) 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds
WO2025017047A1 (en) 2023-07-18 2025-01-23 Janssen Pharmaceutica Nv Combination products of at least three antibiotics comprising bedaquiline, pretomanid or delamanid, and a cytochrome bc1 inhibitor, and their use in the treatment of mycobacterial infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1527050T3 (da) 2002-07-25 2010-07-19 Janssen Pharmaceutica Nv Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
CA2793086C (en) 2010-03-18 2018-08-21 Institut Pasteur Korea Substituted imidazo[1,2-a]pyridine compounds and their use in the treatment of bacterial infections
US9199981B2 (en) 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
EP2751104B1 (en) 2011-09-01 2019-09-25 Novartis AG Compounds and compositions as c-kit kinase inhibitors
US9605002B2 (en) * 2012-07-18 2017-03-28 University Of Notre Dame Du Lac 5,5-heteroaromatic anti-infective compounds
DK3027615T3 (da) 2013-08-02 2021-10-25 Pasteur Institut Korea Antiinfektionsforbindelser
CN105524058B (zh) * 2014-10-21 2018-03-27 广州艾格生物科技有限公司 吡唑并[1,5‑a]吡啶类化合物及其应用
BR112017028318B1 (pt) 2015-07-02 2024-02-20 Janssen Sciences Ireland Uc Composto antibacteriano, seu uso, processo para sua preparação,produto que o contém, composição farmacêutica e combinação
CN108348510B (zh) * 2015-09-17 2022-01-04 圣母大学 针对分枝杆菌感染有用的含有苄胺的杂环化合物以及组合物
BR112018076126A2 (pt) 2016-06-16 2019-03-26 Janssen Sciences Ireland Unlimited Company compostos heterocíclicos como antibacterianos
MX2018015657A (es) * 2016-06-16 2019-03-14 Janssen Sciences Ireland Unlimited Co Compuestos heterociclico como antibacterianos.
WO2018084809A1 (en) * 2016-11-02 2018-05-11 Nanyang Technological University Methods for the treatment or prevention of mycobacterial infections

Similar Documents

Publication Publication Date Title
JP2022548247A5 (https=)
RU2322444C2 (ru) Соединения оксазолидинона, обладающие антибактериальной активностью, способ получения (варианты) и фармацевтическая композиция на их основе
AR059523A2 (es) Azalidas de 13 miembros macrolidos, composiciones farmaceuticas, su uso en la preparacion de medicamentos para el tratamiento de infecciones y procedimientos para preparar estos compuestos.
JP2024508789A5 (https=)
JP2019518050A5 (https=)
JP2019518046A5 (https=)
CA2684105A1 (en) Pyridine derivatives
JP2006501181A5 (https=)
RU2008136187A (ru) Новое производное кумарина, обладающее противоопухолевой активностью
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2004525876A5 (https=)
JP2015512435A5 (https=)
JP2022510925A5 (https=)
RU2003110577A (ru) Гетероциклические соединения, связывающиеся с хемокиновыми рецепторами
KR900018134A (ko) 레트로바이러스성 프로테아제 억제 화합물
JP2005537323A5 (https=)
CA2547347A1 (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
JP2003503385A5 (https=)
JP2009529059A5 (https=)
JP2019500387A5 (https=)
JP2005517006A5 (https=)
JP2021535112A5 (https=)
RU2394028C2 (ru) Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы
CA2494832A1 (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
JP2023520396A5 (https=)